Coeptis Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $200 | $62 | $1,863 | $0 |
Gross Profit | 155 | 17 | 931 | -431 |
EBITDA | -3,961 | -4,056 | -2,673 | -1,499 |
EBIT | -4,266 | -4,362 | -2,933 | -1,777 |
Net Income | -3,534 | -3,057 | -1,947 | -1,828 |
Net Change In Cash | 200 | 62 | 1,863 | 0 |
Free Cash Flow | -2,396 | -2,366 | -1,436 | -1,892 |
Cash | 1,996 | 4,268 | 532 | 1,137 |
Basic Shares | 3,706 | 3,073 | 1,924 | 39,806 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $75 |
Gross Profit | -1,039 | -1,001 | -1,001 | -372 |
EBITDA | -9,442 | -20,158 | -36,354 | -12,815 |
EBIT | -10,481 | -21,159 | -37,355 | -13,262 |
Net Income | -9,814 | -21,267 | -37,574 | -13,449 |
Net Change In Cash | 0 | 0 | 0 | 75 |
Free Cash Flow | -6,649 | -3,875 | -3,875 | -6,239 |
Cash | 532 | 3,791 | 3,791 | 2,179 |
Basic Shares | 1,925 | 25,690 | 14,296 | 1,022 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$1.17 |
2025-03-31 | -$0.95 |
2024-12-31 | -$1.42 |
2024-09-30 | -$1.08 |
